Hai Ying Wang
Hoofd Techniek/Wetenschap/O&O bij Hrain Biotechnology Co., Ltd.
Profiel
Hai Ying Wang is currently a Senior Director of Research & Development at Hrain Biotechnology Co., Ltd.
Prior to this, they earned a doctorate degree from Jilin University in 2012.
Actieve functies van Hai Ying Wang
| Bedrijven | Functie | Begin |
|---|---|---|
Hrain Biotechnology Co., Ltd.
 Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Hai Ying Wang
| Jilin University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Hrain Biotechnology Co., Ltd.
Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | Health Technology |
